FMC [FMC] vs ICL [ICL] Detailed Stock Comparison

FMC

ICL
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: FMC wins in 10 metrics, ICL wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
Metric | FMC | ICL | Better |
---|---|---|---|
P/E Ratio (TTM) | 31.00 | 21.23 | ICL |
Price-to-Book Ratio | 0.92 | 1.45 | FMC |
Debt-to-Equity Ratio | 96.81 | 39.62 | ICL |
PEG Ratio | -0.40 | 15.67 | FMC |
EV/EBITDA | 10.20 | 8.50 | ICL |
Profit Margin (TTM) | 2.42% | 5.66% | ICL |
Operating Margin (TTM) | 15.53% | 10.47% | FMC |
EBITDA Margin (TTM) | 15.53% | 10.47% | FMC |
Return on Equity | 2.93% | 7.30% | ICL |
Return on Assets (TTM) | 3.08% | 4.15% | ICL |
Free Cash Flow (TTM) | $603.20M | $755.00M | ICL |
Dividend Yield | 5.57% | 0.74% | FMC |
1-Year Return | -49.61% | 49.76% | ICL |
Price-to-Sales Ratio (TTM) | 0.97 | 1.25 | FMC |
Enterprise Value | $7.91B | $10.76B | ICL |
EV/Revenue Ratio | 1.91 | 1.57 | ICL |
Gross Profit Margin (TTM) | 38.68% | 31.69% | FMC |
Revenue per Share (TTM) | $33 | $5 | FMC |
Earnings per Share (Diluted) | $1.04 | $0.31 | FMC |
Beta (Stock Volatility) | 0.76 | 1.18 | FMC |
FMC vs ICL Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
FMC | -2.92% | -4.16% | -13.01% | -27.11% | -17.21% | -33.85% |
ICL | 2.89% | 2.30% | 1.63% | -14.77% | 9.68% | 25.60% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
FMC | -49.61% | -70.89% | -70.15% | -3.39% | 7.22% | 181.08% |
ICL | 49.76% | -24.94% | 58.12% | 10.66% | -57.91% | 68.38% |
News Based Sentiment: FMC vs ICL
FMC
News based Sentiment: MIXED
FMC Corporation reported positive Q2 earnings and provided optimistic guidance for Q3 and the full year. However, the initiation of a class action lawsuit and insider selling introduce significant uncertainty, creating a mixed investment narrative. The combination of strong financial performance and legal challenges makes this a pivotal moment for the company.
ICL
News based Sentiment: NEUTRAL
The month of October 2025 presented a stable picture for ICL Group, marked by a significant dividend payout and consistent analyst ratings. While not exhibiting explosive growth, the company demonstrated financial health and continued institutional support, suggesting a reliable, albeit moderate, investment opportunity.
Performance & Financial Health Analysis: FMC vs ICL
Metric | FMC | ICL |
---|---|---|
Market Information | ||
Market Cap | $4.27B | $8.62B |
Market Cap Category | Mid cap | Mid cap |
10 Day Avg. Volume | 2,584,490 | 926,070 |
90 Day Avg. Volume | 2,004,853 | 784,987 |
Last Close | $31.30 | $6.41 |
52 Week Range | $31.14 - $67.75 | $3.91 - $7.35 |
% from 52W High | -53.80% | -12.79% |
All-Time High | $140.99 (Apr 18, 2022) | $26.00 (Jun 16, 2008) |
% from All-Time High | -77.80% | -75.35% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.01% | 0.02% |
Quarterly Earnings Growth | -0.77% | -0.17% |
Financial Health | ||
Profit Margin (TTM) | 0.02% | 0.06% |
Operating Margin (TTM) | 0.16% | 0.10% |
Return on Equity (TTM) | 0.03% | 0.07% |
Debt to Equity (MRQ) | 96.81 | 39.62 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $35.20 | $4.53 |
Cash per Share (MRQ) | $3.51 | $0.34 |
Operating Cash Flow (TTM) | $31.90M | $1.34B |
Levered Free Cash Flow (TTM) | $374.39M | $476.12M |
Dividends | ||
Last 12-Month Dividend Yield | 5.57% | 0.74% |
Last 12-Month Dividend | $2.32 | $0.05 |
Valuation & Enterprise Metrics Analysis: FMC vs ICL
Metric | FMC | ICL |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 31.00 | 21.23 |
Forward P/E | 6.92 | 15.67 |
PEG Ratio | -0.40 | 15.67 |
Price to Sales (TTM) | 0.97 | 1.25 |
Price to Book (MRQ) | 0.92 | 1.45 |
Market Capitalization | ||
Market Capitalization | $4.27B | $8.62B |
Enterprise Value | $7.91B | $10.76B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.91 | 1.57 |
Enterprise to EBITDA | 10.20 | 8.50 |
Risk & Other Metrics | ||
Beta | 0.76 | 1.18 |
Book Value per Share (MRQ) | $35.20 | $4.53 |
Financial Statements Comparison: FMC vs ICL
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | FMC | ICL |
---|---|---|
Revenue/Sales | $1.05B | $1.77B |
Cost of Goods Sold | $644.20M | $1.21B |
Gross Profit | $406.30M | $560.00M |
Research & Development | $66.40M | $18.00M |
Operating Income (EBIT) | $163.10M | $185.00M |
EBITDA | $199.90M | $361.00M |
Pre-Tax Income | $58.80M | $148.00M |
Income Tax | $14.40M | $42.00M |
Net Income (Profit) | $67.80M | $106.00M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | FMC | ICL |
---|---|---|
Cash & Equivalents | $315.30M | $327.00M |
Total Current Assets | $5.08B | $3.59B |
Total Current Liabilities | $3.31B | $2.33B |
Long-Term Debt | $3.03B | $1.91B |
Total Shareholders Equity | $4.41B | $5.99B |
Retained Earnings | $6.55B | $5.76B |
Property, Plant & Equipment | N/A | $4.03B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | FMC | ICL |
---|---|---|
Operating Cash Flow | $-672.60M | $397.00M |
Capital Expenditures | N/A | $-267.00M |
Free Cash Flow | $-589.90M | $185.00M |
Debt Repayment | N/A | $-384.00M |
Common Stock Repurchase | $-1.40M | N/A |
Short Interest & Institutional Ownership Analysis
Metric | FMC | ICL |
---|---|---|
Shares Short | 8.28M | 1.70M |
Short Ratio | 5.14 | 2.39 |
Short % of Float | 0.08% | 0.00% |
Average Daily Volume (10 Day) | 2,584,490 | 926,070 |
Average Daily Volume (90 Day) | 2,004,853 | 784,987 |
Shares Outstanding | 124.84M | 1.29B |
Float Shares | 123.90M | 723.27M |
% Held by Insiders | 0.01% | 0.44% |
% Held by Institutions | 0.98% | 0.24% |
Dividend Analysis & Yield Comparison: FMC vs ICL
Metric | FMC | ICL |
---|---|---|
Last 12-Month Dividend | $2.32 | $0.05 |
Last 12-Month Dividend Yield | 5.57% | 0.74% |
3-Year Avg Annual Dividend | $2.29 | $0.61 |
3-Year Avg Dividend Yield | 0.83% | 1.94% |
3-Year Total Dividends | $6.86 | $1.83 |
Ex-Dividend Date | Mar 31, 2025 | Sep 04, 2024 |